RSS-Feed abonnieren
DOI: 10.1055/s-0029-1219934
An Unprecedented and Concise Method for the Synthesis of 1,3-Thiazino-[3,4a][1,3]benzimidazoles via a Three-Component Reaction
Publikationsverlauf
Publikationsdatum:
10. Mai 2010 (online)

Abstract
For the first time, a novel, simple, and highly efficient synthesis of N-aryl-N-[1,3]thiazino[3,4a][1,3]benzimidazol-1-ylidenamines is presented. The one-pot reaction of o-phenylenediamine, aryl isothiocyanate, and methyl acetylenecarboxylate proceeds in toluene-dichloromethane without any catalyst under reflux conditions to produce the title compounds in 60-70% yield. From a mechanistic point of view, the reaction is proposed to occur via two cyclizations and four heteroatom-carbon bond formations.
Key words
benzimidazole - 1,3-thiazine - thiazinobenzimidazole - methyl propiolate - o-phenylenediamine - aryl isothiocyanate - multicomponent reaction
-
1a
Patel HS.Patel NP. Orient. J. Chem. 1997, 13: 69 -
1b
Madkour HMF.Salem MAI.Soliman EA.Mahmoud NFH. Phosphorus, Sulfur Silicon Relat. Elem. 2001, 170: 15 -
1c
Ingarsal N.Amutha P.Nagarajan S.
J. Sulfur Chem. 2006, 27: 455 -
1d
Tozkoparan B.Aktay G.Yeilada E. Farmaco 2002, 57: 145 - 2
Barret GC.Kane VV.Lowe G. J. Chem. Soc. 1964, 783 - 3
Patani GA.LaVoie E. J. Chem. Rev. 1996, 96: 3147 - 4
Schmidt RR. Synthesis 1972, 333 - 5
Bernalte Garc A.Garc Barros FJ.Higes Rolando FJ.Luna Giles F.Pedrero Mar R. J. Inorg. Biochem. 2004, 98: 15 -
6a
Orjales A.Mosquera R.Labeaga L.Rodes R.
J. Med. Chem. 1997, 40: 586 -
6b
Grimmett MR. Comprehensive Heterocyclic Chemistry II Vol. 3:Katritzky AR.Rees CW.Scriven EF. Elsevier; Oxford: 1996. p.77 - 7
Labanauskas LK.Brukstus AB.Gaidelis PG.Buchinskaite VA.Udrenaite EB.Dauksas VK. Pharm. Chem. J. 2000, 34: 353 -
8a
Ishida T.Suzuki T.Hirashima S.Mizutani K.Yoshida A.Ando I.Ikeda S.Adachi T.Hashimoto H. Bioorg. Med. Chem. Lett. 2006, 16: 1859 -
8b
Garuti L.Roberti M.Gentilomi G. Farmaco 2001, 56: 815 - 9
Iemura R.Kawashima T.Fukuda T.Ito K.Tsukamoto G. J. Med. Chem. 1986, 29: 1178 -
10a
Venkatesan P. J. Antimicrob. Chemother. 1998, 41: 145 -
10b
Pawar NS.Dalal DS.Shimpi SR.Mahulikar PP. Eur. J. Pharm. Sci. 2004, 21: 115 - 11
Valdez J.Cedillo R.Hernandez-Campos A.Yepez L.Hernandez-Luis F.Navarrete-Vazquez G.Tapia A.Cortes R.Hernandez M.Castillo R. Bioorg. Med. Chem. Lett. 2002, 12: 2221 - 12
Mann J.Baron A.Opoku-Boahen Y.Johansson E.Parkinson G.Kelland LR.Neidle S. J. Med. Chem. 2001, 44: 138 - 13
Boiani M.Gonzalez M. Mini-Rev. Med. Chem. 2005, 5: 409 - 14
Mederski WKR.Dorsch D.Anzali S.Gleitz J.Cezanne B.Tsaklakidis C. Bioorg. Med. Chem. Lett. 2004, 14: 3763 - 15
Kubo K.Kohara Y.Yoshimura Y.Inada Y.Shibouta Y.Furukawa Y.Kato T.Nishikawa K.Naka T. J. Med. Chem. 1993, 36: 2343 -
16a
Cole ER.Crank G.Salam-Sheikh A. J. Agric. Food Chem. 1974, 22: 918 -
16b
Ayhan-Kilcigil G.Kus C.Çoban T.Can-Eke B.Ozbey S.Iscan M. J. Enzyme Inhib. Med. Chem. 2005, 20: 503 -
17a
Kai H.Morioka Y.Koriyama Y.Okamoto K.Hasegawa Y.Hattori M.Koike K.Chiba H.Shinohara S.Iwamoto Y.Takahashi K.Tanimoto N. Bioorg. Med. Chem. Lett. 2008, 18: 6444 -
17b
Leflemme N.Dallemagne P.Rault S. Tetrahedron Lett. 2004, 45: 1503 -
17c
Noshio T.Konno Y.Ori M.Sakamoto M. Eur. J. Org. Chem. 2001, 3533 -
17d
Tozkoparan B.Aktay G.Yesilada E. Farmaco 2002, 57: 145 -
17e
Lamberth C.Querniard F. Tetrahedron Lett. 2008, 49: 2286 -
17f
Ryabukhin SV.Plaskon AS.Ostapchuk EN.Volochnyuk DM.Shishkin OV.Shivanyuk AN.Tolmachev AA. Org. Lett. 2007, 9: 4215 -
18a
Middleton RW.Wibberley DG. J. Heterocycl. Chem. 1980, 17: 1757 -
18b
Fairley TA.Tidwell RR.Donkor I.Naiman NA.Ohemeng KA.Lombardy RJ.Bentley JA.Cory M. J. Med. Chem. 1993, 36: 1746 -
18c
Fujiok a H.Murai K.Ohba Y.Hiramatsu A.Kita Y. Tetrahedron Lett. 2005, 46: 2197 -
18d
Peddibhotla S.Tepe JJ. Synthesis 2003, 1433 -
18e
Huh DH.Ryu H.Kim YG. Tetrahedron 2004, 60: 9857 -
18f
Mitchell JM.Finney NS. Tetrahedron Lett. 2000, 41: 8431 -
18g
You SL.Kelly JW. Org. Lett. 2004, 6: 1681 ; and references cited there -
19a
Alizadeh A.Babaki M.Zohreh N.Rezvanian A. Synthesis 2008, 3793 -
19b
Alizadeh A.Hosseinpour R.Rostamnia S. Synthesis 2008, 3742 -
19c
Alizadeh A.Zohreh N.Zhu LG. Tetrahedron 2009, 65: 2684 -
21a
King FD. Tetrahedron 2007, 63: 2053 -
21b
Allin SM.James SL.Martin WP.Smith TAD. Tetrahedron Lett. 2001, 42: 3943
References and Notes
To a magnetically stirred 5 mL flask
containing o-pheny-lenediamine (0.11
g, 1 mmol) and CH2Cl2 (2 mL as solvent) was
added phenyl isothiocyanate (0.14 g, 1 mmol). After 15 min, methyl
acetylenedicarboxylate (0.08 g, 1 mmol) in toluene (5 mL) was added
to the reaction mixture and stirring continued under reflux. After
completion of the reaction (ca. 10 h; monitoring by TLC based on
the presence of intermediate 5), the solvent
was removed under reduced pressure, and the residue was washed with
cold toluene, Et2O, and EtOAc and crystallized from CH2Cl2.
Compound 4a: yield 0.19 g (70%); white
powder; mp 220 ˚C (dec.). IR (KBr): 1685 (C=N),
1663 (C=N), 1638 (C=C), 1589 and 1527 and 1473
and (C=C Ar). ¹H NMR (500.13 MHz, CDCl3): δH = 6.32
(1 H, d, ³
J
H,H = 7.7
Hz, SCHCH), 7.31 (1 H, t, ³
J
H,H = 7.5,
CH of Ar), 7.35 (1 H, t, ³
J
H,H = 7.2
Hz, CH of Ar), 7.44 (2 H, d, ³
J
H,H = 7.6
Hz, 2 CH of Ar), 7.52 (1 H, t, ³
J
H,H = 7.4
Hz, CH of Ar), 7.55 (1 H, d, ³
J
H,H = 7.8
Hz, CH of Ar), 7.60 (2 H, t, ³
J
H,H = 7.5
Hz, 2 CH of Ar), 7.66 (1 H, d, ³
J
H,H = 7.9
Hz, CH of Ar), 8.17 (1 H, d, ³
J
H,H = 7.7
Hz, SCHCH). ¹³C
NMR (125.75 MHz, CDCl3): δC = 106.01
(SCH=CH), 108.49 (CH of Ar),
119.62 (CH of Ar), 122.18 (CH of Ar), 124.90 (CH of Ar), 128.22
(2 CH of Ar), 129.17 (C
ipso
of
Ar), 129.47 (CH of Ar), 129.86 (2 CH of Ar), 132.52 (SCHCH), 134.74 (CH=CHC), 142.41 (C
ipso
of
Ar), 148 (C
ipso
of Ar), 160.38
(N=CS). MS: m/z (%) = 279 (7) [M+ + 2],
277 (6) [M+], 260 (100), 250
(10), 207 (9), 185 (9), 167 (18), 149 (49), 130 (16), 118 (9), 105
(92), 91 (55), 77 (90), 57 (48). 43 (53). Anal. Calcd for C16H11N3S (277.34):
C, 69.29; H, 4; N, 15.15. Found: C, 69.32; H, 4.2; N, 15.13.
Compunds 4e and 4e′:
yield 0.20 g (67%); white powder; mp 230 ˚C
(dec.). IR (KBr): 1676 (2 C=N), 1635 (2 C=N),
1591 (2 C=C), 1533 and 1509 and 1464 and (Ar). ¹H
NMR (500.13 MHz, CDCl3): δH = 2.43
(6 H, s, 2 Me), 2.45 (3 H, s, Me), 2.51 (3 H, s, Me), 6.27 (1 H,
d, ³
J
H,H = 7.7,
SCHCH), 6.28 (1 H, d, ³
J
H,H = 7.8
Hz, SCHCH), 7.11 (1 H, d, ³
J
H,H = 7.9
Hz, CH of Ar), 7.15 (1 H, d,³
J
H,H = 8.2
Hz, CH of Ar), 7.32 (4 H, d, ³
J
H,H = 7.3,
4 CH of Ar), 7.34 (1 H, s, CH of Ar), 7.38 (4 H, d,³
J
H,H = 8.1
Hz, 4 CH of Ar), 7.41 (1 H, d, ³
J
H,H = 8.2
Hz, CH of Ar), 7.45 (1 H, s, CH of Ar), 7.54 (1 H, d, ³
J
H,H = 8.2
Hz, CH of Ar), 8.11 (1 H, d, ³
J
H,H = 7.7Hz, SCHCH), 8.12 (1 H, d, ³
J
H,H = 7.8
Hz, SCHCH). ¹³C
NMR (125.7 MHz, CDCl3): δC = 21.37
(2 Me), 21.71 (Me), 21.75 (Me), 105.62, and 105.79 (2 SCH=CH), 108.01 and 108.59 (2 CH of Ar),
119.17 and 119.65 (2 CH of Ar), 123.28 (2 CH of Ar), 126.14 (2 CH
of Ar), 127.20 (C
ipso
of Ar),
127.87 (2 CH of Ar), 128.90 (C
ipso
of
Ar), 129.30 (C
ipso
of Ar),
130.10 (C
ipso
of Ar), 130.60
(2 CH of Ar), 132.16 and 132.23 (2 CH of Ar), 132.40 and 132.53
(2 SCHCH), 134.83 (2 CH=CHC), 139.43 (2 C
ipso
of
Ar), 140.37 and 142.41 (2 C
ipso
of
Ar), 148.04 (2 C
ipso
of Ar),
160.38 (2 N=CS). MS: m/z (%) = 290
(22), 289 (100), 274 (6), 260 (10), 246 (6), 224 (4), 208 (2), 167
(16), 149 (42), 129 (5), 111 (7), 97 (13), 83 (15), 57 (23), 43
(17). Anal. Calcd for C18H15N3S
(305. 40): C, 70.79; H, 4.95; N, 13.76. Found: C, 70.77; H, 4.97;
N, 13.74.